The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies

J. M. Vose, P. J. Bierman, A. Kessinger, P. F. Coccia, J. Andersen, F. B. Oldham, C. Epstein, J. O. Armitage

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences